Waterdrop Earnings Call Transcripts
Fiscal Year 2025
-
Revenue grew 43.5% year-over-year to RMB 3.98 billion in FY2025, with net profit up 64.8% to RMB 570 million. Insurance and digital health segments saw strong growth, while AI-driven innovations and operational efficiency supported continued profitability and cash generation.
-
A leading insurtech platform in China reported record Q3 2025 revenue and strong profitability, driven by digital insurance brokerage, medical crowdfunding, and AI-powered operations. The company maintains robust cash reserves, consistent shareholder returns, and targets over 20% annual growth.
-
Q3 2025 saw revenue rise 38.4% year-on-year to CNY 975 million and net profit jump 60.1% to CNY 158 million, driven by strong insurance and digital clinical trial segments and significant AI integration. Cash position remained robust at CNY 3.61 billion.
-
Q2 saw 23.9% revenue growth and 85.9% higher operating profit, driven by AI integration and robust insurance and healthcare performance. Enhanced dividend and continued share repurchases reflect strong capital allocation, with positive outlook for sustained growth.
-
Revenue grew 7% year-over-year to RMB 754 million, with net profit up 34.2% and strong insurance segment growth. Annual revenue is expected to rise over 20%, though increased investment may impact profits.
Fiscal Year 2024
-
Solid 2024 results with 5.4% annual revenue growth and doubled net profit, driven by AI and diversified business lines. Insurance SIP rose 24.5% year-over-year, and the company announced a third cash dividend and continued share repurchases.
-
Q3 2024 saw revenue of CNY 704 million and net profit of CNY 92.8 million, up over 150% year-over-year. Insurance and healthcare segments delivered strong growth, while AI and ESG initiatives advanced. Cash reserves remain robust, supporting continued R&D and shareholder returns.
-
Net profit surged 307% year-over-year to CNY 88.3 million, with stable revenue and strong insurance business margins. Continued share repurchases and a new dividend highlight robust capital returns, while AI-driven innovation and operational efficiency support long-term growth.
-
Q1 2024 saw revenue rise 16.3% year-over-year to CNY 705 million and net profit jump 62.2% to CNY 80.6 million, with all segments growing steadily. Insurance and healthcare businesses expanded, and the company maintained strong cash flow and continued share buybacks.